Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent liver diseases globally. Pharmacological treatments for NAFLD are still limited. Silymarin, a compound extracted from Silybum marianum, is an herbal supplement traditionally used in folk medicine for liver dis...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Camila Ribeiro de Avelar, Beatriz Vieira Coelho Nunes, Betina da Silva Sassaki, Mariana dos Santos Vasconcelos, Lucivalda Pereira Magalhães de Oliveira, André Castro Lyra, Allain Amador Bueno, Rosângela Passos de Jesus
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-03-01
Serie:	Trials
Soggetti:	Clinical trial Silymarin Non-alcoholic fatty liver disease randomized controlled trial
Accesso online:	https://doi.org/10.1186/s13063-023-07210-6
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!